cp wire

CP Wire Articles

Eli Lilly Loxo Oncology Transaction Clears A Hurdle

Eli Lilly and Company (NYSE: LLY) (“Lilly”) and Loxo Oncology, Inc. (NASDAQ: LOXO) (“Loxo Oncology”) announcedon 2/1/19 the expiration of the waiting period under the Hart-Scott-Rodino Antitrust... read more

Fri, 02/1/19 - 09:43 am
MorphoSys Settles Patent Lawsuit with Janssen and Genmab

MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced on 1/31/19 that in its lawsuit against Janssen Biotech and Genmab A/S, the parties have settled the... read more

Fri, 02/1/19 - 09:25 am
Sunovion Receives Complete Response Letter from FDA for Parkinson’s Disease Drug
  • The FDA is requiring additional information and analyses
  • No new cliincal studies are required


Sunovion Pharmaceuticals Inc. (Sunovion) announced on 1/31/19 that the... read more

Thu, 01/31/19 - 10:19 am
BioXyTran Files for $10 Million Offering to Advance Stroke and Wound Healing Candidates

BioXyTran has filed for an offering of common stock that will bring in approximately $10 million. The company has two candidates that it intends to advance to pre-clinical development with the... read more

Thu, 01/31/19 - 10:05 am
Azitra Completes Enrollment in Clinical Trial of Topical Commensal Microbiological Agent

Azitra, Inc., a company developing microbiome-based cosmetics and therapeutics to treat skin diseases and conditions, announced today that enrollment has been completed for the first human safety... read more

Wed, 01/30/19 - 10:18 am

Pages